These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38277621)

  • 1. Allogeneic Hematopoietic Cell Transplantation Ameliorated Asymptomatic Granulomatous and Lymphocytic Interstitial Lung Disease in a Patient With XIAP Deficiency.
    Oshima M; Matsukawa Y; Ikeda Y; Sakamoto K; Taga T; Maruo Y
    J Pediatr Hematol Oncol; 2024 Mar; 46(2):e191-e194. PubMed ID: 38277621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. X-linked Inhibitor of Apoptosis Complicated by Granulomatous Lymphocytic Interstitial Lung Disease (GLILD) and Granulomatous Hepatitis.
    Steele CL; Doré M; Ammann S; Loughrey M; Montero A; Burns SO; Morris EC; Gaspar B; Gilmour K; Bibi S; Shendi H; Devlin L; Speckmann C; Edgar DM
    J Clin Immunol; 2016 Oct; 36(7):733-8. PubMed ID: 27492372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granulomatous lymphocytic interstitial lung disease.
    Fernández Pérez ER
    Immunol Allergy Clin North Am; 2012 Nov; 32(4):621-32. PubMed ID: 23102069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hematopoietic Cell Transplantation Rescues Inflammatory Bowel Disease and Dysbiosis of Gut Microbiota in XIAP Deficiency.
    Ono S; Takeshita K; Kiridoshi Y; Kato M; Kamiya T; Hoshino A; Yanagimachi M; Arai K; Takeuchi I; Toita N; Imamura T; Sasahara Y; Sugita J; Hamamoto K; Takeuchi M; Saito S; Onuma M; Tsujimoto H; Yasui M; Taga T; Arakawa Y; Mitani Y; Yamamoto N; Imai K; Suda W; Hattori M; Ohara O; Morio T; Honda K; Kanegane H
    J Allergy Clin Immunol Pract; 2021 Oct; 9(10):3767-3780. PubMed ID: 34246792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does shining a spotlight on XIAP deficiency bring the role of allogeneic HCT into better focus?
    Marsh RA
    J Allergy Clin Immunol; 2022 Aug; 150(2):297-298. PubMed ID: 35716950
    [No Abstract]   [Full Text] [Related]  

  • 6. Allogeneic hematopoietic cell transplantation for XIAP deficiency: an international survey reveals poor outcomes.
    Marsh RA; Rao K; Satwani P; Lehmberg K; Müller I; Li D; Kim MO; Fischer A; Latour S; Sedlacek P; Barlogis V; Hamamoto K; Kanegane H; Milanovich S; Margolis DA; Dimmock D; Casper J; Douglas DN; Amrolia PJ; Veys P; Kumar AR; Jordan MB; Bleesing JJ; Filipovich AH
    Blood; 2013 Feb; 121(6):877-83. PubMed ID: 23131490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment Strategies for GLILD in Common Variable Immunodeficiency: A Systematic Review.
    Lamers OAC; Smits BM; Leavis HL; de Bree GJ; Cunningham-Rundles C; Dalm VASH; Ho HE; Hurst JR; IJspeert H; Prevaes SMPJ; Robinson A; van Stigt AC; Terheggen-Lagro S; van de Ven AAJM; Warnatz K; van de Wijgert JHHM; van Montfrans J
    Front Immunol; 2021; 12():606099. PubMed ID: 33936030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haploidentical Hematopoietic Stem Cell Transplantation for XIAP Deficiency: a Single-Center Report.
    Yang J; Zhu GH; Wang B; Zhang R; Jia CG; Yan Y; Ma HH; Qin MQ
    J Clin Immunol; 2020 Aug; 40(6):893-900. PubMed ID: 32627096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Common variable immunodeficiency with granulomatous-lymphocytic interstitial lung disease and preceding neurological involvement: a case-report.
    Cowen JE; Stevenson J; Paravasthu M; Darroch J; Jacob A; Tueger S; Gosney JR; Simons A; Spencer LG; Judge EP
    BMC Pulm Med; 2020 Jul; 20(1):205. PubMed ID: 32736614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hematopoietic cell transplantation for monogenic inflammatory bowel disease].
    Kanegane H; Tomomasa D; Tanita K
    Rinsho Ketsueki; 2023; 64(9):1213-1221. PubMed ID: 37899202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rituximab Monotherapy Is Effective as First-Line Treatment for Granulomatous Lymphocytic Interstitial Lung Disease (GLILD) in CVID Patients.
    Tessarin G; Baronio M; Gazzurelli L; Rossi S; Chiarini M; Moratto D; Giliani SC; Bondioni MP; Badolato R; Lougaris V
    J Clin Immunol; 2023 Nov; 43(8):2091-2103. PubMed ID: 37755605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced-Intensity/Reduced-Toxicity Conditioning Approaches Are Tolerated in XIAP Deficiency but Patients Fare Poorly with Acute GVHD.
    Arnold DE; Nofal R; Wakefield C; Lehmberg K; Wustrau K; Albert MH; Morris EC; Heimall JR; Bunin NJ; Kumar A; Jordan MB; Cole T; Choo S; Brettig T; Speckmann C; Ehl S; Salamonowicz M; Wahlstrom J; Rao K; Booth C; Worth A; Marsh RA
    J Clin Immunol; 2022 Jan; 42(1):36-45. PubMed ID: 34586554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granulomatous-lymphocytic interstitial lung disease as the first manifestation of common variable immunodeficiency.
    Tashtoush B; Memarpour R; Ramirez J; Bejarano P; Mehta J
    Clin Respir J; 2018 Jan; 12(1):337-343. PubMed ID: 27243233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency-Features of CT and
    Fraz MSA; Moe N; Revheim ME; Stavrinou ML; Durheim MT; Nordøy I; Macpherson ME; Aukrust P; Jørgensen SF; Aaløkken TM; Fevang B
    Front Immunol; 2020; 11():617985. PubMed ID: 33584710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rapid flow cytometric screening test for X-linked lymphoproliferative disease due to XIAP deficiency.
    Marsh RA; Villanueva J; Zhang K; Snow AL; Su HC; Madden L; Mody R; Kitchen B; Marmer D; Jordan MB; Risma KA; Filipovich AH; Bleesing JJ
    Cytometry B Clin Cytom; 2009 Sep; 76(5):334-44. PubMed ID: 19288545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using flow cytometry to screen patients for X-linked lymphoproliferative disease due to SAP deficiency and XIAP deficiency.
    Marsh RA; Bleesing JJ; Filipovich AH
    J Immunol Methods; 2010 Oct; 362(1-2):1-9. PubMed ID: 20816973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Predictors of a Diagnosis of Common Variable Immunodeficiency-related Granulomatous-Lymphocytic Interstitial Lung Disease.
    Mannina A; Chung JH; Swigris JJ; Solomon JJ; Huie TJ; Yunt ZX; Truong TQ; Brown KK; Achcar RD; Olson AL; Cox CW; Kligerman SJ; Curran-Everett D; Fernández Pérez ER
    Ann Am Thorac Soc; 2016 Jul; 13(7):1042-9. PubMed ID: 27064856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granulomatous Lymphocytic Interstitial Lung Disease (GLILD) in Common Variable Immunodeficiency (CVID): A Multicenter Retrospective Study of Patients From Italian PID Referral Centers.
    Cinetto F; Scarpa R; Carrabba M; Firinu D; Lougaris V; Buso H; Garzi G; Gianese S; Soccodato V; Punziano A; Lagnese G; Tessarin G; Costanzo G; Landini N; Vio S; Bondioni MP; Consonni D; Marasco C; Del Giacco S; Rattazzi M; Vacca A; Plebani A; Fabio G; Spadaro G; Agostini C; Quinti I; Milito C
    Front Immunol; 2021; 12():627423. PubMed ID: 33777011
    [No Abstract]   [Full Text] [Related]  

  • 19. Rituximab and antimetabolite treatment of granulomatous and lymphocytic interstitial lung disease in common variable immunodeficiency.
    Verbsky JW; Hintermeyer MK; Simpson PM; Feng M; Barbeau J; Rao N; Cool CD; Sosa-Lozano LA; Baruah D; Hammelev E; Busalacchi A; Rymaszewski A; Woodliff J; Chen S; Bausch-Jurken M; Routes JM
    J Allergy Clin Immunol; 2021 Feb; 147(2):704-712.e17. PubMed ID: 32745555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rituximab Monotherapy for Common Variable Immune Deficiency-Associated Granulomatous-Lymphocytic Interstitial Lung Disease.
    Ng J; Wright K; Alvarez M; Hunninghake GM; Wesemann DR
    Chest; 2019 May; 155(5):e117-e121. PubMed ID: 31060706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.